Stock to Buy Today: Pfizer

Popular Posts:

• 6 Stocks to Sell in May
• In My 45 Years in the Market, I Have Never Seen Anything Like This
• Top 6 Stocks to Buy for May

Recent Posts:

• Have We Seen the Highs for the Summer?
• Homebuilder on the Verge of a Double-Top Breakout
• Will the Key Reversal Day Be the Market’s Kiss of Death?
• View All Posts

Pfizer (NYSE:PFE) — The world’s largest pharmaceutical company has had a long history of earnings increases that have resulted in higher dividends. The current dividend yield is 3.7%. Analysts have raised their price target to $28-$30.

Technically PFE broke from resistance at $23 after a long series of corrections, each of which held on its bullish support line. The breakout is supported by a new buy signal from our proprietary indicator, the Collins-Bollinger-Reversal (CBR), and a short-term buy signal from the stochastic. The trading target is $30, but Pfizer is an investment-grade stock that should be held for long-term appreciation.

Pfizer reports Q2 earnings before Tuesday’s opening. Analysts are looking for EPS of 52 cents, but they may be surprised with a few cents more plus a dividend increase.

Click to Enlarge